Gerard J. Criner

53.3k total citations · 13 hit papers
511 papers, 20.5k citations indexed

About

Gerard J. Criner is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Gerard J. Criner has authored 511 papers receiving a total of 20.5k indexed citations (citations by other indexed papers that have themselves been cited), including 439 papers in Pulmonary and Respiratory Medicine, 124 papers in Physiology and 73 papers in Surgery. Recurrent topics in Gerard J. Criner's work include Chronic Obstructive Pulmonary Disease (COPD) Research (328 papers), Respiratory Support and Mechanisms (201 papers) and Asthma and respiratory diseases (90 papers). Gerard J. Criner is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (328 papers), Respiratory Support and Mechanisms (201 papers) and Asthma and respiratory diseases (90 papers). Gerard J. Criner collaborates with scholars based in United States, United Kingdom and Germany. Gerard J. Criner's co-authors include Fernando J. Martínez, Frank C. Sciurba, MeiLan K. Han, Victor Kim, Bartolomé R. Celli, Barry J. Make, Robert A. Wise, John M. Travaline, Edwin K. Silverman and Francis Cordova and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Gerard J. Criner

474 papers receiving 19.9k citations

Hit Papers

Tocilizumab in Pa... 1998 2026 2007 2016 2020 2011 2018 2010 2010 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
    2020 798 citations Gerard J. Criner et al. profile →
  2. Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society
    2011 771 citations Gerard J. Criner et al. profile →
  3. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
    2018 758 citations David A. Lipson, Gerard J. Criner et al. profile →
  4. Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
    2010 726 citations MeiLan K. Han, Àlvar Agustí et al. American Journal of Respiratory and Critical Care Medicine profile →
  5. A Randomized Study of Endobronchial Valves for Advanced Emphysema
    2010 514 citations Frank C. Sciurba, Gerard J. Criner et al. profile →
  6. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome
    1998 491 citations Gerard J. Criner et al. profile →
  7. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
    2020 463 citations David Halpin, Gerard J. Criner et al. American Journal of Respiratory and Critical Care Medicine profile →
  8. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
    2017 452 citations Antonio Anzueto, Gerard J. Criner et al. European Respiratory Journal profile →
  9. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
    2017 384 citations Ian Pavord, Gerard J. Criner et al. profile →
  10. Chronic Bronchitis and Chronic Obstructive Pulmonary Disease
    2012 327 citations Gerard J. Criner et al. American Journal of Respiratory and Critical Care Medicine profile →
  11. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision
    2022 244 citations Bartolomé R. Celli, Leonardo M. Fabbri et al. American Journal of Respiratory and Critical Care Medicine profile →
  12. COPD and multimorbidity: recognising and addressing a syndemic occurrence
    2023 112 citations Leonardo M. Fabbri, Bartolomé R. Celli et al. The Lancet Respiratory Medicine profile →
  13. Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
    2025 22 citations Frank C. Sciurba, Gerard J. Criner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerard J. Criner United States 71 15.8k 5.6k 1.8k 1.4k 1.3k 511 20.5k
Frank C. Sciurba United States 69 15.0k 0.9× 5.3k 0.9× 1.2k 0.7× 2.0k 1.3× 1.6k 1.2× 300 19.0k
Neil R. MacIntyre United States 46 16.5k 1.0× 7.4k 1.3× 1.7k 0.9× 1.7k 1.2× 743 0.6× 211 21.9k
Ryan T. McKay Canada 35 20.3k 1.3× 11.0k 2.0× 1.7k 0.9× 1.7k 1.1× 2.4k 1.8× 82 27.7k
Vito Brusasco Italy 46 23.4k 1.5× 12.9k 2.3× 1.9k 1.0× 1.6k 1.1× 802 0.6× 210 29.0k
Margaret Rosenfeld United States 61 13.1k 0.8× 2.3k 0.4× 1.9k 1.1× 2.5k 1.7× 2.1k 1.6× 233 18.1k
Msm Ip Hong Kong 54 8.7k 0.5× 9.5k 1.7× 1.4k 0.7× 1.9k 1.3× 1.2k 0.9× 346 18.6k
Claus Vogelmeier Germany 65 18.9k 1.2× 9.8k 1.8× 1.2k 0.6× 2.1k 1.4× 2.4k 1.8× 515 26.2k
Donald W. Cockcroft Canada 50 8.1k 0.5× 8.2k 1.5× 2.4k 1.3× 2.0k 1.4× 1.3k 1.0× 226 22.7k
Robert A. Stockley United Kingdom 59 16.0k 1.0× 6.3k 1.1× 895 0.5× 2.0k 1.4× 2.1k 1.6× 328 21.9k
Jadwiga A. Wedzicha United Kingdom 75 21.6k 1.4× 9.6k 1.7× 638 0.3× 3.3k 2.3× 940 0.7× 253 24.8k

Countries citing papers authored by Gerard J. Criner

Since Specialization
Citations

This map shows the geographic impact of Gerard J. Criner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard J. Criner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard J. Criner more than expected).

Fields of papers citing papers by Gerard J. Criner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard J. Criner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard J. Criner. The network helps show where Gerard J. Criner may publish in the future.

Co-authorship network of co-authors of Gerard J. Criner

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard J. Criner. A scholar is included among the top collaborators of Gerard J. Criner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard J. Criner. Gerard J. Criner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Martinez, Fernando J., Gerard J. Criner, Lee Tombs, et al.. (2024). ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD. European Respiratory Journal. 65(2). 2400171–2400171. 3 indexed citations
3.
Astor, Todd L., Hilary J. Goldberg, Laurie D. Snyder, et al.. (2023). Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis. Therapeutic Advances in Respiratory Disease. 17. 2683745240–2683745240. 4 indexed citations
4.
Sin, Don D., Dany Doiron, Àlvar Agustí, et al.. (2023). Air pollution and COPD: GOLD 2023 committee report. European Respiratory Journal. 61(5). 2202469–2202469. 75 indexed citations
5.
Fabbri, Leonardo M., Bartolomé R. Celli, Àlvar Agustí, et al.. (2023). COPD and multimorbidity: recognising and addressing a syndemic occurrence. The Lancet Respiratory Medicine. 11(11). 1020–1034. 112 indexed citations breakdown →
6.
Zhang, Yuhang, Michael R. Hoopmann, Peter J. Castaldi, et al.. (2021). Lung proteomic biomarkers associated with chronic obstructive pulmonary disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 321(6). L1119–L1130. 27 indexed citations
7.
Patel, M., A.J. Gangemi, R. Marron, et al.. (2020). Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure. BMJ Open Respiratory Research. 7(1). e000650–e000650. 49 indexed citations
8.
Bahmed, Karim, Dhanendra Tomar, Nathaniel Marchetti, et al.. (2019). The relationship between DJ-1 and S100A8 in human primary alveolar type II cells in emphysema. American Journal of Physiology-Lung Cellular and Molecular Physiology. 317(6). L791–L804. 8 indexed citations
9.
Moimas, Silvia, Francesco Salton, Beata Kośmider, et al.. (2019). miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation. ERJ Open Research. 5(4). 138–2019. 46 indexed citations
10.
Bhatt, Surya P., John E. Connett, Helen Voelker, et al.. (2016). β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol. BMJ Open. 6(6). e012292–e012292. 22 indexed citations
11.
Celli, Bartolomé R., Kay Tetzlaff, Gerard J. Criner, et al.. (2016). The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool: Insights from the COPD Biomarker Qualification Consortium. American Journal of Respiratory and Critical Care Medicine. 194(12). 1483–1493. 86 indexed citations
12.
Benzo, Roberto, Max H. Farrell, Fernando J. Martínez, et al.. (2009). Integrating Health Status and Survival Data: The Palliative Effect of Lung Volume Reduction Surgery. American Journal of Respiratory and Critical Care Medicine. 180(3). 239–246. 26 indexed citations
13.
Criner, Gerard J. & Gilbert E. D’Alonzo. (2002). Critical care study guide : text and review. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 8 indexed citations
14.
Chatila, Wissam, Satoshi Furukawa, & Gerard J. Criner. (2000). Acute Respiratory Failure after Lung Volume Reduction Surgery. American Journal of Respiratory and Critical Care Medicine. 162(4). 1292–1296. 8 indexed citations
15.
Criner, Gerard J., Francis Cordova, Satoshi Furukawa, et al.. (1999). Prospective Randomized Trial Comparing Bilateral Lung Volume Reduction Surgery to Pulmonary Rehabilitation in Severe Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 160(6). 2018–2027. 192 indexed citations
16.
Furukawa, Satoshi, et al.. (1999). Effect of Lung Volume Reduction Surgery on Diaphragm Length in Severe Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 159(3). 796–805. 70 indexed citations
17.
Cordova, Francis, et al.. (1999). Relationship between Resting Hypercapnia and Physiologic Parameters before and after Lung Volume Reduction Surgery in Severe Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 159(5). 1405–1411. 27 indexed citations
18.
Criner, Gerard J., Francis Cordova, Vadim Leyenson, et al.. (1998). Effect of Lung Volume Reduction Surgery on Diaphragm Strength. American Journal of Respiratory and Critical Care Medicine. 157(5). 1578–1585. 78 indexed citations
19.
Travaline, John M., et al.. (1997). Recovery of PdiTwitch Following the Induction of Diaphragm Fatigue in Normal Subjects. American Journal of Respiratory and Critical Care Medicine. 156(5). 1562–1566. 19 indexed citations
20.
Travaline, John M., et al.. (1997). Effect of N -Acetylcysteine on Human Diaphragm Strength and Fatigability. American Journal of Respiratory and Critical Care Medicine. 156(5). 1567–1571. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank C. Sciurba Breakdown of academic impact, for papers by Neil R. MacIntyre Breakdown of academic impact, for papers by Ryan T. McKay Breakdown of academic impact, for papers by Vito Brusasco Breakdown of academic impact, for papers by Margaret Rosenfeld Breakdown of academic impact, for papers by Msm Ip Breakdown of academic impact, for papers by Claus Vogelmeier Breakdown of academic impact, for papers by Donald W. Cockcroft Breakdown of academic impact, for papers by Robert A. Stockley Breakdown of academic impact, for papers by Jadwiga A. Wedzicha
Rankless by CCL
2026